Michael J. Labarre

Companies

• Halozyme TherapeuticsVP, Product Development Dec 13, 2010 to Feb 27, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HTHalozyme Therapeutics HALO173,756 shares²$21.4M at $122.96Feb 27, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 27, 2025Sold 100 shares at $58.74 of Halozyme Therapeutics²
• Feb 27, 2025Sold 1,597 shares at $58.25 of Halozyme Therapeutics²
• Feb 26, 2025Sold 600 shares at $58.65 of Halozyme Therapeutics²
• Feb 26, 2025Sold 9,400 shares at $58.09 of Halozyme Therapeutics²
• Feb 25, 2025Sold 700 shares at $58.67 of Halozyme Therapeutics²
• Feb 25, 2025Sold 9,300 shares at $58.01 of Halozyme Therapeutics²
• Feb 23, 2025Shares withheld for tax 2,410 shares at $57.75 of Halozyme Therapeutics³
• Feb 23, 2025Exercised options 4,747 shares of Halozyme Therapeutics³
• Feb 16, 2025Shares withheld for tax 2,164 shares at $58.29 of Halozyme Therapeutics⁴
• Feb 16, 2025Exercised options 4,263 shares of Halozyme Therapeutics⁴
• Feb 16, 2025Shares withheld for tax 3,103 shares at $58.29 of Halozyme Therapeutics⁴
• Feb 16, 2025Exercised options 6,112 shares of Halozyme Therapeutics⁴
• Feb 16, 2025Shares withheld for tax 8,721 shares at $58.29 of Halozyme Therapeutics⁴
• Feb 16, 2025Exercised options 20,891 shares of Halozyme Therapeutics⁴
• Feb 15, 2025Shares withheld for tax 1,304 shares at $58.29 of Halozyme Therapeutics⁴
• Feb 15, 2025Exercised options 3,386 shares of Halozyme Therapeutics⁴
• Oct 16, 2024Sold 10,000 shares at $53.26 of Halozyme Therapeutics⁵
• Oct 16, 2024Exercised options 10,000 shares at $19.98 of Halozyme Therapeutics⁵
• Oct 15, 2024Sold 77 shares at $54.25 of Halozyme Therapeutics⁵
• Oct 15, 2024Sold 9,923 shares at $53.74 of Halozyme Therapeutics⁵
• Oct 15, 2024Exercised options 4,491 shares at $19.98 of Halozyme Therapeutics⁵
• Oct 15, 2024Exercised options 5,509 shares at $16.65 of Halozyme Therapeutics⁵
• Sep 18, 2024Sold 2,037 shares at $62.58 of Halozyme Therapeutics⁶
• Sep 18, 2024Sold 7,963 shares at $61.89 of Halozyme Therapeutics⁶
• Sep 18, 2024Exercised options 10,000 shares at $16.65 of Halozyme Therapeutics⁶